Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients

BACKGROUND: Reduced physical activity is associated with increased morbidity and mortality in patients with COPD. Studies suggest that treatment with the long-acting muscarinic antagonist tiotropium and the long-acting β(2)-agonist olodaterol increases exercise capacity. This study assessed the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Valipour, Arschang, Tamm, Michael, Kociánová, Jana, Bayer, Valentina, Sanzharovskaya, Maria, Medvedchikov, Alexey, Haaksma-Herczegh, Monika, Mucsi, János, Fridlender, Zvi, Toma, Claudia, Belevskiy, Andrey, Matula, Bohumil, Šorli, Jurij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6793952/
https://www.ncbi.nlm.nih.gov/pubmed/31632003
http://dx.doi.org/10.2147/COPD.S204388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6793952/
https://www.ncbi.nlm.nih.gov/pubmed/31632003
http://dx.doi.org/10.2147/COPD.S204388

Ejemplares similares